U.S. Markets closed

L'Oréal S.A. (LRLCY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
42.54-0.07 (-0.16%)
At close: 3:59PM EDT
People also watch
LVMUYBASFYDDAIYBAYRYSIEGY
Full screen
Previous Close42.61
Open42.72
Bid0.00 x 0
Ask0.00 x 0
Day's Range42.36 - 42.80
52 Week Range33.38 - 43.95
Volume33,088
Avg. Volume86,750
Market Cap117.33B
Beta0.58
PE Ratio (TTM)27.96
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.72 (1.68%)
Ex-Dividend Date2017-04-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube12 days ago

    ETFs with exposure to L’Oréal SA : September 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to L’Oréal SA Here are 5 ETFs with the largest exposure to LRLCY-US. Comparing the performance and risk of L’Oréal SA with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Valeant Pharmaceuticals Intl Inc (VRX) Stock Falls on New Legal Battle
    InvestorPlace23 days ago

    Valeant Pharmaceuticals Intl Inc (VRX) Stock Falls on New Legal Battle

    Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was under pressure last week amid reports that mutual fund company Lord Abbett & Co. has filed a securities fraud lawsuit against Valeant, alleging that it bought VRX’s debt securities at artificially inflated price based on misleading information provided by Valeant. The lawsuit Lord Abbett filed in federal court in New Jersey — location of Valeant’s U.S. headquarter — seeks damages of $80 billion in investor losses and under the New Jersey’s racketeer influenced and corrupt organizations (RICO) laws. There have been tons of reason to be skeptical about Valeant Pharmaceuticals’ future and, in particular, the company’s ability to pay its massive debt pile of $28.5 billion, while it has just $1.5 billion in cash.

  • L’Oréal SA :LRLCY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 10, 2017
    Capital Cubelast month

    L’Oréal SA :LRLCY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 10, 2017

    Categories: Yahoo FinanceGet free summary analysis L’Oréal SA reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of L’Oréal SA – Procter & Gamble Company, Revlon, Inc. Class A, Avon Products, Inc., Inter Parfums, Inc., Unilever PLC Sponsored ADR, Sally Beauty Holdings, Inc. and Sanofi Sponsored ADR ... Read more (Read more...)